Search

Search Constraints

You searched for: Author/Creator Fredi, Micaela

Search Results

3. AB0481 AUTOANTIBODIES' TITRE MODULATION BY ANTI-BLYS TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019)

5. Anti-MJ/NXP-2 antibodies are the most common specifcity in a cohort of adult caucasian patients with dermatomyositis. (22nd February 2012)

7. Association of Natural Killer Cell Ligand Polymorphism HLA–C Asn80Lys With the Development of Anti‐SSA/Ro–Associated Congenital Heart Block. Issue 11 (17th October 2017)

8. Brief Report: Association of Natural Killer Cell Ligand Polymorphism HLA–C Asn80Lys With the Development of Anti‐SSA/Ro–Associated Congenital Heart Block. Issue 11 (17th October 2017)

9. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Issue 7 (16th February 2022)

10. Correction to: Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis. (26th February 2022)